Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
The peptide did not produce adverse metabolic effects associated with full-length growth hormone, including insulin resistance, glucose intolerance, or IGF-1 elevation
This creates a concentration of 2,500 mcg/mL (2.5 mg/mL)
AOD-9604 is the modified 16-amino-acid version with an added N-terminal tyrosine that improves stability
The lyophilization process preserves peptide stability and allows researchers to reconstitute the compound for controlled in vitro experimentation
And avoid strongly alkaline conditions, which alter copper coordination and can precipitate hydroxide species
Preclinical research evidence Animal Experiments Obese mouse model: After subcutaneous injection of AOD 9604 (250 g/kg) daily for 8 weeks, the body weight of obese mice decreased by 12%, the subcutaneous fat mass decreased by 25%, and the weight of epididymal adipose tissue decreased significantly
US$ 25.80
US$ 28.21
US$ 29.79
US$ 23.73
US$ 23.74
